Literature DB >> 12219053

Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction.

Teal S Hallstrand1, J Randall Curtis, Thomas D Koepsell, Diane P Martin, Robert B Schoene, Sean D Sullivan, Gerald N Yorioka, Moira L Aitken.   

Abstract

OBJECTIVE: To determine if a physician-administered physical examination and screening questionnaire accurately detects exercise-induced bronchoconstriction (EIB) in adolescent athletes. STUDY
DESIGN: Cross-sectional study of 256 adolescents participating in organized sports from 3 suburban high schools. The number of persons screened positive for EIB by physical examination and questionnaire was compared with the number of persons with EIB diagnosed by a "gold standard" test that consisted of a 7-minute exercise challenge followed by serial spirometry.
RESULTS: We diagnosed EIB in 9.4% of adolescent athletes. The screening history identified persons with symptoms or a previous diagnosis suggestive of EIB in 39.5% of the participants, but only 12.9% of these persons actually had EIB. Among adolescents with a negative review of symptoms of asthma or EIB, 7.8% had EIB. Among adolescents with no previous diagnosis of asthma, allergic rhinitis, or EIB, 7.2% had EIB diagnosed by exercise challenge. Persons who screened negative on all questions about symptoms or history of asthma, EIB, and allergic rhinitis accounted for 45.8% of the adolescents with EIB.
CONCLUSIONS: EIB occurs frequently in adolescent athletes, and screening by physical examination and medical history does not accurately detect it.

Entities:  

Mesh:

Year:  2002        PMID: 12219053     DOI: 10.1067/mpd.2002.125729

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Quality of life in adolescents with mild asthma.

Authors:  Teal S Hallstrand; J Randall Curtis; Moira L Aitken; Sean D Sullivan
Journal:  Pediatr Pulmonol       Date:  2003-12

2.  Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression.

Authors:  Regina R Pillai; Rohit Divekar; Allan Brasier; Suresh Bhavnani; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

3.  Airway immunopathology of asthma with exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Moira L Aitken; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

4.  Screening for exercise-induced bronchoconstriction in college athletes.

Authors:  Jonathan P Parsons; David Cosmar; Gary Phillips; Christopher Kaeding; Thomas M Best; John G Mastronarde
Journal:  J Asthma       Date:  2012-01-25       Impact factor: 2.515

Review 5.  Asthma adherence and the athlete.

Authors:  Ivan D Cardona; Christopher M Mjaanes; Jack M Becker
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

Review 6.  Highlights in asthma 2005.

Authors:  J L Heraghty; A J Henderson
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

7.  Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction.

Authors:  Chris Carlsten; Moira L Aitken; Teal S Hallstrand
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

8.  Impact of changes in the IOC-MC asthma criteria: a British perspective.

Authors:  J W Dickinson; G P Whyte; A K McConnell; M G Harries
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 9.  Pediatric exercise-induced bronchoconstriction: contemporary developments in epidemiology, pathogenesis, presentation, diagnosis, and therapy.

Authors:  Christopher Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

10.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.